Workflow
Shenzhen Friendcom Technology Development (300514)
icon
Search documents
友讯达(300514.SZ)中标约1.61亿元南方电网相关项目
智通财经网· 2025-09-11 10:58
智通财经APP讯,友讯达(300514.SZ)发布公告,近日,公司收到了招标代理机构南方电网供应链集团有 限公司发来的《中标通知书》,招标项目:南方电网公司2025年计量设备第一批框架招标项目(招标编 号:CG2700022002051852),中标金额约1.61亿元。 ...
友讯达中标约1.61亿元南方电网相关项目
Zhi Tong Cai Jing· 2025-09-11 10:54
友讯达(300514)(300514.SZ)发布公告,近日,公司收到了招标代理机构南方电网供应链集团有限公 司发来的《中标通知书》,招标项目:南方电网公司2025年计量设备第一批框架招标项目(招标编号: CG2700022002051852),中标金额约1.61亿元。 ...
友讯达:中标南方电网公司2025年计量设备第一批框架招标项目,金额1.61亿元
Xin Lang Cai Jing· 2025-09-11 10:54
友讯达9月11日晚间公告,公司近日收到招标代理机构南方电网供应链集团有限公司发来的《中标通知 书》,中标南方电网公司2025年计量设备第一批框架招标项目,中标金额约为1.61亿元。 ...
友讯达(300514.SZ):中标1.61亿元南方电网招标项目
Ge Long Hui A P P· 2025-09-11 10:16
格隆汇9月11日丨友讯达(300514.SZ)公布,2025年9月1日,中国南方电网有限责任公司在其供应链统一 服务平台发布了《南方电网公司2025年计量设备第一批框架招标项目中标公示》(招标编号: CG2700022002051852),公司为上述招标项目中标候选人,预中标金额约为人民币1.61亿元。近日, 公司收到了招标代理机构南方电网供应链集团有限公司发来的《中标通知书》。 ...
友讯达:中标金额约1.61亿元南方电网项目
Xin Lang Cai Jing· 2025-09-11 10:16
Core Viewpoint - The company has received a bid notification for the first batch of metering equipment framework tender project from Southern Power Grid Company for 2025, with a bid amount of approximately 161 million RMB, which represents 15.90% of the company's audited revenue for 2024 [1] Group 1 - The bid amount of approximately 161 million RMB is expected to have a positive impact on the company's operations and performance in 2025 [1] - This successful bid reflects the company's competitive advantages and recognition of its overall strength [1] - The project is likely to enhance the company's market share and brand influence in the power industry [1]
友讯达(300514) - 关于收到中标通知书的公告
2025-09-11 10:04
本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚假 记载、误导性陈述或重大遗漏。 证券代码:300514 证券简称:友讯达 公告编号:2025-039 深圳友讯达科技股份有限公司 关于收到中标通知书的公告 二、项目中标对公司的影响 公司自成立以来,一直专注于为各行业提供无线物联网综合解决方案,所有 1 2025年9月1日,中国南方电网有限责任公司在其供应链统一服务平台发布了 《南方电网公司2025年计量设备第一批框架招标项目中标公示》(招标编号:C G2700022002051852),深圳友讯达科技股份有限公司(以下简称"公司")为上 述招标项目中标候选人,预中标金额约为人民币16,057.09万元。具体内容详见公 司于2025年9月2日在中国证监会指定的创业板信息披露网站巨潮资讯网(http:// www.cninfo.com.cn)上披露的《关于重大经营活动中标的公告》(公告编号:2 025-037)。 近日,公司收到了招标代理机构南方电网供应链集团有限公司发来的《中标 通知书》,现将具体事项公告如下: 一、中标通知书的主要内容 1、招标项目:南方电网公司2025年计量设备第一批框架招标 ...
友讯达:公司产品暂不涉及大功率充电设施
Xin Lang Cai Jing· 2025-09-10 13:11
Group 1 - The company stated on July 10 that its products do not currently involve high-power charging facilities [1]
友讯达(300514) - 关于控股股东、实际控制人及其一致行动人减持股份触及1%整数倍的公告
2025-09-10 12:54
证券代码:300514 证券简称:友讯达 公告编号:2025-038 深圳友讯达科技股份有限公司 关于控股股东、实际控制人及其一致行动人减持股份触及1% 整数倍的公告 信息披露义务人云南威而来斯企业管理中心(有限合伙)、云南友讯企业 管理中心(有限合伙)保证向本公司提供的信息内容真实、准确、完整,没有 虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚 假记载、误导性陈述或重大遗漏。 深圳友讯达科技股份有限公司(以下简称"公司"或"友讯达")于2025年7月8 日披露了《关于特定股东减持股份的预披露公告》(公告编号:2025-032),公 司特定股东云南威而来斯企业管理中心(有限合伙)(以下简称"威而来斯") 计划自公告披露之日起15个交易日后的3个月内以集中竞价或大宗交易方式减持 公司股份不超过1,335,937股(占公司总股本0.67%),公司特定股东云南友讯企业 管理中心(有限合伙)(以下简称"云南友讯")计划自公告披露之日起15个交 易日后的3个月内以集中竞价或大宗交易方式减持公司股份不超过620,516股(占 公司总股本0.31%)。 公司于近日收到威 ...
9月3日晚间重要公告一览
Xi Niu Cai Jing· 2025-09-03 10:18
Group 1 - Shengtun Mining plans to repurchase shares worth between 500 million and 600 million yuan, with a maximum repurchase price of 11.82 yuan per share, aimed at employee stock ownership plans or equity incentives [1] - Kangnbei received a drug registration certificate for Linggui Shugan Granules, which is derived from traditional Chinese medicine and is used for treating phlegm and dampness due to Yang deficiency [2] - Zhangjiang Hi-Tech intends to publicly transfer 100% equity and related debts of Shanghai Jixin Rui Construction Technology Co., Ltd. with a total price not less than 151 million yuan [3] Group 2 - Shankai Intelligent won a bid for a metering device procurement project worth 13.318 million yuan from Hohhot Water Supply Company [4] - Hason Co. plans to jointly establish a supply chain company with a registered capital of 10 million yuan, in which Hason will hold a 10% stake [5] - Pudong Construction's subsidiaries won multiple major projects with a total amount of 1.271 billion yuan [6] Group 3 - Jinling Pharmaceutical received approval for the Phase III clinical trial of Olaratogrel tablets, which are used for treating moderate to severe pain associated with endometriosis [8] - Menohua's subsidiary obtained a drug registration certificate for Mosapride Citrate Tablets, aimed at improving gastrointestinal symptoms [10] - Shapuaisi's major shareholder plans to reduce holdings by up to 2% of the company's shares due to personal financial needs [11] Group 4 - Changyuan Power reported an August electricity generation of 3.771 billion kWh, a year-on-year decrease of 6.03% [15][16] - Xibu Livestock's August fresh milk production increased by 4.8% month-on-month but decreased by 7.27% year-on-year [19] - Yong'an Pharmaceutical's actual controller and chairman had their detention lifted, allowing them to resume normal duties [20] Group 5 - Jinkai Intelligent's director resigned due to work adjustments [22] - Xinhua Medical received a Class II medical device registration for an endoscope cleaning workstation [23] - Haishi Science and Technology's innovative drug HSK47388 received approval for a new indication clinical trial [25] Group 6 - Baotai Co. plans to participate in a land use rights auction in Baoji City with a starting price of 57.34 million yuan [26] - Minfeng Special Paper received a government subsidy totaling 11.2 million yuan [27] - Jiuchang Bio obtained a medical device registration for a heparin-binding protein assay kit [29] Group 7 - Jingao Technology plans to repurchase shares worth between 200 million and 400 million yuan, with a maximum price of 17.36 yuan per share [31] - Youxunda won a bid for a metering equipment project from China Southern Power Grid worth approximately 161 million yuan [32] - Qianli Technology reported an August vehicle sales increase of 168.55% year-on-year [32] Group 8 - Guangzhou Port expects an August container throughput increase of 1.2% year-on-year [32] - Kexing Pharmaceutical's GB08 injection completed the first subject enrollment for Phase II clinical trials [33] - Wu Ming Pharmaceutical plans to transfer 98.9% of its subsidiary's shares to a newly established wholly-owned subsidiary [34] Group 9 - Shanghai Electric's acquisition of K-Electric Limited shares has not yet completed the transfer [35] - Fulai New Materials plans to raise no more than 710 million yuan through a private placement [36] - Huaren Health's drug registration application for a new type of potassium ion competitive acid blocker has been accepted [37]
友讯达:公司一直致力于为各行业提供物联网综合解决方案
Zheng Quan Ri Bao· 2025-09-03 10:15
Core Viewpoint - The company is focused on providing comprehensive IoT solutions across various industries, emphasizing the development and application of wireless sensor networks in the IoT field [2] Group 1 - The company has successfully applied its self-developed MuCoFAN wireless IoT field network technology in multiple industry scenarios, including digital power grids, smart energy management, and green low-carbon transformation [2] - The technology demonstrates the capability to build a ubiquitous, intelligent, and secure IoT ecosystem [2]